# Kamiya Biomedical Company, LLC, Tukwila, WA – FDA Inspections

Source: https://www.keypedia.com/companies/kamiya-biomedical-company-llc/af1cce98-35e5-4696-bade-77b35b7c84d6

> Inspection records and compliance data for Kamiya Biomedical Company, LLC in Tukwila, Washington. 5 FDA inspections on record, last inspected May 16, 2024.

---

## Details

- Name: Kamiya Biomedical Company, LLC
- FEI Number: 2084025
- Address Line 1: 12779 Gateway Dr S
- City: Tukwila
- State: Washington
- Zip Code: 98168
- Country Name: United States
- Address: 12779 Gateway Dr S, Tukwila, Washington 98168, United States
- Country: United States

## Related Documents

- FDA Inspection 1241704 - Kamiya Biomedical Company, LLC - 2024-05-16 — classification: No Action Indicated (NAI), source: FDA, date: May 16, 2024
- [FDA Inspection 1241704 - Kamiya Biomedical Company, LLC - 2024-05-16](https://www.keypedia.com/records/fda_inspections/kamiya-biomedical-company-llc/840cab50-42a8-4dd6-9995-2e2ef4180537) — classification: No Action Indicated (NAI), source: FDA, date: May 16, 2024
- FDA Inspection 916099 - Kamiya Biomedical Company, LLC - 2015-02-26 — classification: No Action Indicated (NAI), source: FDA, date: February 26, 2015
- FDA Inspection 824015 - Kamiya Biomedical Company, LLC - 2013-03-21 — classification: No Action Indicated (NAI), source: FDA, date: March 21, 2013
- FDA Inspection 824015 - Kamiya Biomedical Company, LLC - 2013-03-21 — classification: No Action Indicated (NAI), source: FDA, date: March 21, 2013
- FDA Inspection 731362 - Kamiya Biomedical Company, LLC - 2011-06-15 — classification: No Action Indicated (NAI), source: FDA, date: June 15, 2011
- FDA Inspection 731362 - Kamiya Biomedical Company, LLC - 2011-06-15 — classification: No Action Indicated (NAI), source: FDA, date: June 15, 2011
- FDA Inspection 554423 - Kamiya Biomedical Company, LLC - 2008-12-16 — classification: No Action Indicated (NAI), source: FDA, date: December 16, 2008
- FDA Inspection 554423 - Kamiya Biomedical Company, LLC - 2008-12-16 — classification: No Action Indicated (NAI), source: FDA, date: December 16, 2008

## Related Companies

- [Franciscan Health System Med. Research Eval. Committee](https://www.keypedia.com/companies/franciscan-health-system-med-research-eval-committee/4671bbbb-ca60-470a-aa4e-5ac7bef4244e)
- [David B. Jessup, MD](https://www.keypedia.com/companies/david-b-jessup-md/b60b75d2-c554-4d80-8edc-040efd3e9fb0)
- [Tate Technology, Inc.](https://www.keypedia.com/companies/tate-technology-inc/938bec13-e9ae-4092-826b-d140a41babec)
- [John NK Hsiang MD](https://www.keypedia.com/companies/john-nk-hsiang-md/f1f16dae-8ba3-4c0e-aeeb-66f5c61d1617)
- [Cardea Associtates](https://www.keypedia.com/companies/cardea-associtates/ee48afec-11e0-4b53-8965-f63219c995b3)
- [CV Medical, LLC](https://www.keypedia.com/companies/cv-medical-llc/f9d4e9d6-7ac5-4192-b8f2-a59e928e2dc3)
- [KHL Inc](https://www.keypedia.com/companies/khl-inc/6190dad8-9f82-477a-b96d-0232a9251808)
- [Nor Consult LLC](https://www.keypedia.com/companies/nor-consult-llc/8621e95d-be2a-402b-abdc-518ea25d2dc3)
- [Genprime Inc](https://www.keypedia.com/companies/genprime-inc/d722549c-d1df-4ff0-9a6f-0656a70ff76b)
- [Pierre P Leimgruber MD](https://www.keypedia.com/companies/pierre-p-leimgruber-md/d939171d-e6a9-4c45-930e-f92fce440856)